Related references
Note: Only part of the references are listed.High-sensitivity cardiac troponin I and T methods for the early detection of myocardial injury in patients on chemotherapy
Aldo Clerico et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2021)
Coronavirus Disease 2019 (COVID-19): A Systematic Review of Imaging Findings in 919 Patients
Sana Salehi et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2020)
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options
Tomasz J. Guzik et al.
CARDIOVASCULAR RESEARCH (2020)
COVID-19 and Cardiovascular Disease
Kevin J. Clerkin et al.
CIRCULATION (2020)
Short-term biological variation and diurnal rhythm of cardiac troponin I (Access hs-TnI) in healthy subjects
Martina Zaninotto et al.
CLINICA CHIMICA ACTA (2020)
Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis
Xintao Li et al.
HEART (2020)
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes
Denis Doyen et al.
LANCET (2020)
COVID-19 pneumonia: A review of typical CT findings and differential diagnosis
C. Hani et al.
DIAGNOSTIC AND INTERVENTIONAL IMAGING (2020)
Clinical utility of cardiac troponin measurement in COVID-19 infection
David C. Gaze
ANNALS OF CLINICAL BIOCHEMISTRY (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality
Robert O. Bonow et al.
JAMA CARDIOLOGY (2020)
Cardiac Troponin for Assessment of Myocardial Injury in COVID-19 JACC Review Topic of the Week
Yader Sandoval et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Myocardial injury and COVID-19: Possible mechanisms
Savalan Babapoor-Farrokhran et al.
LIFE SCIENCES (2020)
High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study
Xiaoming Jia et al.
CIRCULATION (2019)
Clinical Laboratory Practice Recommendations for the Use of Cardiac Troponin in Acute Coronary Syndrome: Expert Opinion from the Academy of the American Association for Clinical Chemistry and the Task Force on Clinical Applications of Cardiac Bio-Markers of the International Federation of Clinical Chemistry and Laboratory Medicine
Alan H. B. Wu et al.
CLINICAL CHEMISTRY (2018)
Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury
Andrew R. Chapman et al.
CIRCULATION (2018)
Fourth Universal Definition of Myocardial Infarction (2018)
Kristian Thygesen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Association of Repeatedly Measured High-Sensitivity Assayed Troponin I with Cardiovascular Disease Events in a General Population from the MORGAM/BiomarCaRE Study
Maria F. Hughes et al.
CLINICAL CHEMISTRY (2017)
Quantifying the Release of Biomarkers of Myocardial Necrosis from Cardiac Myocytes and Intact Myocardium
Jack Marjot et al.
CLINICAL CHEMISTRY (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
Troponin elevation in coronary vs. non-coronary disease
S. Agewall et al.
EUROPEAN HEART JOURNAL (2011)
Share Paper
